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Abstract: Background: For surgical interventions classified as clean or clean-contaminated, including
laparotomy, guidelines in human and veterinary medicine recommend a short-term perioperative
antibiotic prophylaxis (PAP). In equine colic surgery, however, PAP commonly exceeds 24 h. Objec-
tives: The aim of this study was to compare a single-shot to a 5-day lasting PAP considering surgical
site infections (SSI) and other adverse effects probably associated with the particular antimicrobial
regimen. Study design: The study was designed as a randomised non-inferiority pilot study includ-
ing horses subjected to colic surgery while receiving one of two distinct PAP regimens. Methods:
All horses (n = 67) included in the study received the standard physical examination before and
after surgery. Colic surgery was performed according to the current standard of the clinic. Horses
were randomly assigned to two groups, receiving either the “single-shot” or the “5-day lasting”
antibiotic prophylaxis. The “single-shot” group (n = 30) received penicillin and gentamicin only
once before and, if needed, during surgery, whereas the “5-day lasting” group (n = 37) received
antibiotics for five days. In addition to the standard laboratory examinations, serum amyloid A and
fibrinogen were determined preoperatively and during five days after surgery. SSI, postoperative
colitis and haemolytic anaemia were classified as postoperative complications potentially related to
antibiotic use. Results: The outcome of this preliminary non-inferiority clinical trial showed that the
occurrence of postoperative adverse events (i.e., SSI, postoperative colitis and haemolytic anaemia)
lacked significant differences between the study groups. Main limitations: The main limitations of
this study are the limited group sizes and our inability to blind the study. Conclusions: Single-shot
PAP seems to be an alternative approach considering the 5-day lasting protocol commonly used in
equine abdominal surgery. However, a proper hygiene management together with a close clinical
and laboratory monitoring of the equine patient is indispensable.
Keywords: colic; laparotomy; perioperative antibiotics; surgical site infection; colitis; haemolytic
anaemia; horse
1. Introduction
The abdominal pain syndrome complex caused by disorders of the gastrointestinal
tract in horses is commonly referred to as “colic” [1]. An annual incidence of 4.2% was
reported for the prevalence of equine colic in the United States, including 1.4% of horses
which required emergency laparotomy [1]. According to Cruse and Foord [2], abdominal
surgery, such as equine exploratory laparotomy, is either classified as a clean (i.e., without
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enterotomy and/or resection) or clean-contaminated (i.e., with enterotomy and/or resec-
tion) surgical procedure. Surgical site infections (SSI) are among the most common adverse
events after colic surgery, alongside postoperative colic/pain, postoperative ileus, severe
endotoxaemic shock, jugular thrombophlebitis and postoperative colitis [3–6].
Incisional wound healing is not only influenced by the preoperative preparation of
the surgical site, skills of the surgeon, the procedures and techniques used during the inter-
vention [7,8], but also by the systemic health state of the horse. Since the horse’s recovery
and return to athletic function can be impaired by complications in incisional healing such
as SSI [7,8], prevention of SSI and other adverse effects is crucial after colic surgery.
Furthermore, the rational use of antibiotics is considered a key factor to maintain the
effectiveness of important antibiotic agents, which is of utmost importance, considering
the limited antibiotics currently available for horses, at least in Germany [9–12]. Moreover,
decreasing the inevitable selective effects of antibiotics, by enhancing their rational use,
counteracts the spread of antimicrobial resistance among pathogens known to commonly
cause SSI in horses. The latter includes Gram-positive and -negative bacteria residing on
the skin and mucosal surfaces of horses [13]. Considering the onset of postoperative SSI,
antibiotics are administered in the immediate perioperative period, a precaution which is
known as perioperative antibiotic prophylaxis (PAP) [14,15].
A “single-shot” antibiotic application is considered sufficient in human medicine in
cases of clean-contaminated surgery such as laparotomy [14]. However, in equine laparo-
tomy, the most commonly applied perioperative antibiotic regimens seem to regularly
exceed 24 h [16,17]. Equine patients have special needs concerning their environment and
housing (i.e., large stables with non-skid floors, litter, dust and manure). Thus, keeping
pathogenic bacteria able to cause postoperative infections at bay is often challenging com-
pared to the situation associated with clinical environments of human or even small animal
healthcare facilities [9,10]. These considerations may have an impact on the surgeons’
decision on prolongation of the actual PAP.
A single antibiotic dose seems sufficient to avoid SSI for various kinds of surgery for
human patients lacking additional risk factors, such as advanced age, a chronic disease
or pre-existing infections [15,18,19]. Nonetheless, if a surgical intervention exceeds 3 h
or antibiotics which require frequent re-dosing (≥3x/day) are used, a repetition dose is
recommended after two half-lives of the antibiotic agent selected [14]. Antibiotics which
are administered beyond the timeframe of 24 h postoperatively are generally considered
as therapy [14,15]. Different studies have already verified the lack of benefit of prolonged
(>24 h) antibiotic administration in cases of clean-contaminated human surgeries [15,18,19].
A previous study found no significant difference between a 72 and 120 h antibiotic
protocol regarding SSI rates after equine colic surgery [17]. So far, the rates reported for SSI
after median laparotomy in horses range from 15% to 50% [6,17,20–23], with even increased
rates reported for horses undergoing re-laparotomy (83%) [17,24].
Healthcare-associated infections in horses have often seemed to be associated with
multidrug-resistant (MDR) bacteria [10,25,26], including SSI [25,27]. In addition, our previ-
ous studies have revealed that horses entering an equine clinic may already be colonised
with MDR bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) (i.e., nostrils,
3.5%) [27,28] and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae
(i.e., intestinal carriage, 10.7%) [26,29].
Therefore, it seems essential to promote the rational use of antibiotics and even
reconsider standardised protocols for PAP in equine surgery.
The primary focus of this pilot randomised clinical trial with a non-inferiority design
was to determine that a short-term PAP is not associated with more clinical adverse events
(i.e., SSI, postoperative colitis and drug-induced haemolytic anaemia) than a conventional
5-day lasting PAP protocol in equine colic surgery (=non-inferiority trial). The secondary
outcomes included assessment of blood parameters and bacteria associated with SSI in
both study groups.
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2. Material and Methods
2.1. Ethical Statement
According to the German regulation authorities for research with animal subjects,
the comparison of two antibiotic regimens does not require approval (Landesamt für
Gesundheit und Soziales, Berlin, 18.04.2017). Written owner’s consent to involve their
horses in the study was obtained during the admission process at the clinic.
2.2. Study Population
Non-inferiority trial calculation (Sealed Envelope Ltd. 2012. Power calculator for
binary outcome non-inferiority trial. [Online, last accessed 03/2021] Available from:
https://www.sealedenvelope.com/power/binary-noninferior/) was used to calculate
the sample sizes for this pilot study. Considering the literature on SSI following colic
surgery [6,17,20–23] a conservative minimum of 10% for SSI (and other adverse events)
was assumed for both groups, resulting in the assumption of success (lack of SSI and
other adverse events) in 90% of the equine patients. Based on the wide range of rates
reported for the most frequently occurring adverse event following colic surgery SSI (15%
to 50% [6,8,17,20–22]) and the pilot feasibility character of the study, the study power was
set to 60% and the inferiority limit to 15%. With a 5% significance level, a sample size of 29
was calculated per group (total: 58). In order to strengthen the study power, we decided to
include more equine patients, if possible. However, when benzylpenicillin for veterinary
use was (temporarily) not available from September 2019 forward and the remainders ran
out in 2020, the study was terminated.
Horses were randomised to the PAP regimens in a 1:1 ratio. Randomisation was
performed in the theatre after wound closure to prevent performance bias using sealed
envelopes (1:1 ratio) which have been stored in a closed box. The box content was checked
with respect to coherence by counting the remaining envelopes each week. This was an
open-label trial as the different antibiotic regimens prevented blinding.
Colic patients (n = 99) that were presented to the clinic and required laparotomy from
January 2018 to February 2020 were considered as study participants. Metadata collected
for each case included breed, age, gender and weight (Supplemental Table S1). The time
of general anaesthesia, the medical indication for surgical intervention and, if applicable,
the necessity for an enterotomy and/or intestinal resection was recorded for each patient.
Surgeries in which an enterotomy and/or a resection was required were considered as clean-
contaminated surgeries, whereas surgeries without enterotomy and/or resection were
considered as clean surgeries. Since an intestinal resection is generally more invasive than
an enterotomy, the two procedures were treated separately during the statistical evaluation.
Horses (n = 11) which suffered from an infectious disease preoperatively or from any
other condition requiring continuing antibiotic treatment were excluded from participation.
Furthermore, all horses receiving antibiotics which were not in strict compliance with
the study protocol (i.e., during nightshifts, due to intraoperative contamination) were
removed from both study groups (n = 12). In addition, horses that were euthanised (during
surgery or shortly afterwards), those subjected to a second surgical intervention within
three days postoperatively, or horses that did not survive the third day after surgery (day
of first bandage change, n = 9) were not considered for statistical evaluation. Otherwise,
horses were further investigated regarding SSI, postoperative colitis and clinical signs
of haemolytic anaemia. None of the horses were euthanised because of an incisional
wound infection.
Following up, we contacted equine patient owners over telephone (March 2020),
asking whether there had been any signs of wound-healing disorders or other adverse
events after the hospital discharge of their horses. A period of 3 weeks to 25 months had
passed between the surgical intervention and these follow-up calls.
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2.3. Clinical Examinations and Diagnostic Laparotomy
All horses were examined physically, transrectally and sonographically upon arrival.
A nasogastric tube placement was performed on all horses with signs of acute colic as
part of the standard hospital procedure. In addition to the common laboratory diagnostics
(complete blood-count and blood-gas analysis), serum amyloid A (SAA) and fibrinogen
values were determined to monitor increased inflammatory reaction, possibly indicating
adverse events, including SSI.
Surgical intervention in horses with colic was performed according to the current
in-house protocol. The muscle layer was closed in a continuous pattern with Polysorb loop
(Lactomer 9-1) 2 USP. Each surgical site was flushed with 0.9% sterile sodium chloride
(KOCHSALZLÖSUNG 0.9% B. Braun Spüllsg. Ecotainer, B. Braun Melsungen AG, Melsun-
gen/Germany) before applying intra-cuticular sutures with Monocryl 2-0. The surgical
wound was covered (NOBARAPID®, NOBAMED Paul Danz AG, Wetter (Ruhr)/Germany),
fixed with Hypafix® (BSN medical GmbH, Hamburg/Germany) and an abdominal ban-
dage consisting of adhesive bandages (RUDALASTIK®, NOBAMED Paul Danz AG, Wetter
(Ruhr)/Germany) was applied before the horse was transported to the recovery box. Each
horse was closely monitored after surgery and further medical care was individually ad-
justed. Every patient received flunixin-meglumine (1.1 mg/kg, twice a day, (BID) Flunidol®
RPS, CP-Pharma Handelsgesellschaft mbH, Burgdorf/Germany) for 5 days after surgery.
To prevent catheter-related thrombosis, horses received either low-molecular heparin (tin-
zaparin 50 IU/kg once daily (SID), INNOHEP multi 10.000 Anti-Xa IE/mL, 2 mL Dsfl,
Kohlpharma GmbH, Merzig/Germany) or un-fractioned heparin (Heparin-Natrium Braun
“Multi” 10,000 IE/mL, B. Braun Melsungen AG, Melsungen/Germany) in decreasing
dosages, starting with 100 IU/kg BID. Due to the European veterinary medicine legislation,
only horses which were excluded from human consumption were treated with doses of
low-molecular heparin. Postoperative check-ups during the following 5 days included,
beyond others, a complete blood count, evaluation of the acid-base status, determination
of inflammatory markers (i.e., SAA and fibrinogen) and electrolyte ratios twice a day. A
final regular check was accomplished on the tenth day.
On the third day after surgery, the abdominal bandage was routinely changed. Ad-
ditional changes were carried out whenever considered necessary. In most cases, the
abdominal bandage was removed on day 5. A standardised wound evaluation was per-
formed on days 3, 5 and 10 after surgery. An SSI was diagnosed by the veterinarian in
charge, considering, beyond others, seropurulent or purulent exudation from the inci-
sional site and/or suture dehiscence with or without a positive microbiological culture
result. Complications other than SSI, which are possibly associated with the antibiotic
protocol, were defined as postoperative colitis and drug-induced haemolytic anaemia. A
comprehensive overview illustrating the post-surgical follow-ups is presented in Figure 1.
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Figure 1. Illustration summarising the general post-surgical care and examinations applied to horses with colic surgery.
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2.4. Perioperative Antibiotic Prophylaxis
The PAP in this study included sodium penicillin G (22,000 IU/kg, Penicillin-G-
Natrium, bela pharm GmbH und Co. KG, Vechta/Germany or INFECTOCILLIN® par-
enteral 10 Mega, INFECTOPHARM Arzneimittel und Consilium GmbH, Heppenheim/
Germany) and gentamicin (6.6 mg/kg, Genta 100 mg/mL, CP-Pharma Handelsgesellschaft
mbH, Burgdorf/Germany), as reported for colic surgery previously [17,30,31]. In each
case, the antibiotics were administered under general anaesthesia 30–60 min before the
initial incision. Since colic surgeries commonly last more than 3 h, sodium penicillin G was
re-dosed after two of the agent’s half-lives (22,000 IU/kg).
While horses belonging to the SSG did not receive further antibiotics, 5DG horses
received antibiotics for 120 h in total (penicillin (22,000 IE four times daily QID) and
gentamicin (6.6 mg/kg SID)). The latter PAP regimen has been reported previously [17]. It
was not possible to blind the study due to medical reasons.
2.5. Statistical Analysis
The IBM SPSS version 25 (Armonk, New York, USA) was used for statistical analysis.
Normal distribution of continuous data was assessed by visual inspection (histogram,
qq-plot, boxplot) and by descriptive characteristics (mean, median, kurtosis, skewness).
The χ2-test and Fisher’s exact test (if more than 25% of the cells had expected counts < 5)
were used for categorical variables to test for significant differences between groups. A
one-factorial analysis of variance (ANOVA) was performed for ordinally scaled variables.
The t-test was used to compare continuous values between two groups (normal distributed
variables, i.e., age). The Wilcoxon–Mann–Whitney U test was used for non-normally
distributed parameters (preoperative SAA, SAA on day 10).
Two multivariable logistic regression models were applied to investigate the influence
of enterotomy, resection and study group with respect to the probability to develop SSI
within 10 days/30 days after surgery, respectively. Odds ratios (OR), along with their 95%




Here, we report on 67 horses which fulfilled the inclusion criteria for this study, with
30 horses belonging to the SSG and 37 to the 5DG. A detailed overview of each horse’s
gender, breed, age and kind of abdominal surgery is provided in Supplemental Table S1.
There was no significant difference regarding the distribution of horse breeds between the
study groups (p = 0.09, Fisher’s exact test). Six horses were stallions (all 5DG), 31 geldings
(16, SSG; 15, 5DG) and 30 mares (14, SSG; 16, 5DG). There was no significant difference
with respect to gender between the groups (p = 0.06, Fisher’s exact test).
3.2. Postoperative Events
A total of three horses (1 SSG; 2 5DG) underwent relaparotomy within 3–10 days
after surgery, and one of them was euthanised (5DG) because a bladder carcinoma was
suspected. A further five horses were euthanised (2 SSG; 3 5DG) within 3–10 days after the
surgical intervention. None of the horses enrolled in this study were euthanised because
of an adverse event possibly associated with the antibiotic regimen, especially SSI, colitis
or haemolytic anaemia. Three horses were discharged before the tenth day after surgery
(1 SSG; 2 5DG). Information about six horses (5 SSG; 1 5DG) was not achieved by follow-up
telephone calls.
3.3. Adverse Events Following Colic Surgery Which Were Probably Associated with the
PAP Regimen
As a result, 8 of 30 (26.6%) horses belonging to the SSG and 7 of 37 (18.9%) equine
patients of the 5DG showed an adverse event following colic surgery. Since the limit was
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set at 15%, the difference of 7.7% indicates non-inferiority of the single-shot antibiotic
regimen (study power: 60%). A comprehensive overview of all SSI cases together with
adverse events possibly associated with the PAP regimen is provided in Table 1.
Table 1. Adverse events following colic surgery possibly associated with the antibiotic regimen (p.o. = postoperatively).
Surgical Site Infections (SSI)








10 Torsio coli SSI − + E. faecium
13 Ileal obstipation SSI + + E. cloacae (ESBL)
19 Ileal obstipation SSI + + MRSA, E. coli, Fusobacteriumspp., B. fragiles
23a Caecal obstipation Colitis − − -
28 Nephrosplenicentrapment SSI − +
E. coli, K. pneumoniae, MRSA,
E. faecium
29 Lipoma pendulans SSI + + E. coli, E. cloacae, E. faecium
46 Obstipation of theascending colon SSI − + n.a.
66 Lipoma pendulans SSI + + E. cloacae
5DG
12 Obstipation of theascending colon Colitis − − -
18 Incarceration of theascending colon Haemolytic anaemia − − -
33 Torsio caeci withincarcerated jejunum Colitis − − -
41 Lipoma pendulans SSI + + E. aerogenes (ESBL), MRSA
56 a Meteorism of the colon Colitis − − -
60 Diaphragmatic hernia Haemolytic anaemia − − -
62 Lipoma pendulans Colitis, Haemolytic anaemia − + n.a.
The table shows adverse events noted for horses belonging to the SSG and those recorded for horses which received antibiotics at 5 days
(5DG) after surgery. Abbreviations: ID, individual horse number (also see Supplemental Table S1), 10 days, onset of SSI within 10 days
following surgery; 30 days, SSI developed within 30 days after surgery; *, ≥3 days after surgery; +, horse developed SSI; −, horse did not
develop SSI. a: horse with colitis and Clostridium perfringens-positive faecal sample; E. faecium, Enterococcus faecium; E. cloacae, Enterobacter
cloacae; MRSA, methicillin resistant Staphylococcus aureus; E. coli, Escherichia coli; B. fragiles, Bacteriodes fragiles; E. aerogenes, Enterobacter
aerogenes; K. pneumoniae, Klebsiella pneumoniae; ESBL, extended-spectrum beta-lactamase-producing.
Altogether, 4 of 30 horses belonging to the SSG (13%) and 1 of 37 horses belonging
to the 5DG (3%) developed a SSI within 10 days after surgery (Table 2), a difference that
lacked significance (p = 0.2, Fisher’s exact test).
Considering the onset of SSI within 30 days after surgery, one horse (SSG) that was
hospitalised for more than 10 days developed a purulent infection on day 12. Another
horse (SSG) was presented to the clinic because of SSI on day 15 following surgery. Two
further horses (1 SSG; 1 5DG), for which microbiological culture results were unfortunately
not available, developed SSI within 30 days after surgery (Table 2).
Again, the recorded cases of SSI which occurred within 30 days after surgery lacked
statistical significance between the SSG and the 5DG (p = 0.07, Fisher’s exact test). Incisional
hernia was reported for one case (SSG). However, the specific day of the incident was
not available.
Results recorded for horses with and without enterotomy and/or resection did not
differ significantly considering the development of SSI during the first 10 days after surgery
(multivariable logistic regression, global p = 0.1). However, analysing SSI that occurred
Antibiotics 2021, 10, 587 7 of 14
within 30 days after surgery (data obtained by follow-up calls), horses that required en-
terotomy almost significantly more often developed SSI than horses without enterotomy
(p = 0.051, OR = 15.4, 95% CI 0.99–240, multivariable regression, global p = 0.03). Fur-
thermore, there was no significant difference in the development of both SSI within 10
(p = 0.503, chi squared test) and 30 days (p = 0.583, chi squared test) between clean and
clean-contaminated procedures (Table 2).
Table 2. Comprehensive overview of study groups and study outcomes.
Single-Shot Group 5-Day Group
n = 30 n = 37 p
n % n %
Surgical site infections (SSI)
SI within 10 days after surgery 4 13 1 3 0.17
total SSI 7 23 2 5 0.07
Classification of surgery
clean 12 40 9 24 0.13
clean-contaminated 18 60 28 76 0.13
contaminated 0 0 0 0
Colitis 1 3 4 11 0.37
Haemolytic anaemia 0 0 3 8 0.25
Data available on horses belonging to the SSG and the 5DG included age
(13.5 ± 7.6 years versus 13.6 ± 7.7 years; p = 0.5, t-test), duration of general anaes-
thesia (2.9 ± 2.3 h versus 2.9 ± 2.3 h, p = 0.6, Wilcoxon–Mann–Whitney U test) and
hospitalisation time (12.7 ± 4.5 days versus 12.6 ± 4.5 days, p = 0.6, t-test), and lacked
significant differences. Details for each horse are presented in Supplemental Table S1.
The probable cause of the abdominal disorders associated with colic was most often
localised in the large intestine (n = 37), followed by dysfunction of the small intestine
(n = 21). Both intestine parts seemed to be affected in eight horses, and a further horse
suffered from a diaphragmatic hernia (all details are provided in Supplemental Table S1).
The study groups investigated here (SSG versus 5DG) lacked significant differences regard-
ing the location (large intestine/small intestine/both) of the intestinal disorder (p = 0.8,
Fisher’s exact test). Furthermore, there was no significant difference between the groups
regarding classification, according to Cruse and Foord [3], of the surgery (clean: 12 SSG,
9 5DG; clean-contaminated: 18 SSG, 28 5DG; p = 0.19).
Enterotomy was performed in 39 horses (17 SSG; 22 5DG; p = 0.8, chi squared test)
and intestinal resection in 12 horses (1, SSG; 11, 5DG; p = 0.005, OR 12.269, chi squared test).
Thus, there was no difference regarding the necessity for enterotomy between the groups,
but horses assigned to the 5DG needed a resection significantly more often.
Besides SSI, adverse events which are commonly associated with the administration
of antibiotics in horses were recorded. Five horses developed postoperative colitis, four
of them were assigned to the 5DG and one to the SSG (p = 0.2, Fisher’s exact test, OR
3.52, 95% CI 0.37–33.26). Penicillin, gentamicin and non-steroidal anti-inflammatory drugs
(NSAID) were discontinued, and the horses received fluids, probiotics and metronidazole.
Clostridium perfringens was detected using microbiological cultures in two faecal samples
obtained from these horses (Table 1).
In addition, clinical signs of haemolytic anaemia have been perceived in three further
cases (all 5DG; p = 0.1). An abrupt cessation of penicillin and gentamicin administration
was followed by a restored physiological haematocrit in all cases. None of these patients
required blood transfusion. For postoperative adverse events, the classification (clean
versus clean-contaminated) lacked statistical significance (colitis: p = 0.142, chi squared
test, haemolytic anaemia: p = 0.317, chi squared test).
Antibiotics 2021, 10, 587 8 of 14
3.4. Bacteria Associated with SSI
Bacteria isolated from samples of SSI (Table 1) included common enteric bacteria
such as Enterococcus faecium, Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae and
Enterbacter aerogens. Most of these bacteria exhibited antimicrobial resistance towards more
than four different antibiotic classes, justifying their classification as MDR. In addition,
three wound swabs were also positive for MRSA.
3.5. Laboratory Tests
We monitored the white blood-cell count, SAA and fibrinogen of horses belonging
to both study groups. Mean values, standard deviation/median and the range of non-
normally distributed values are displayed in Table 3. Some samples were not available
due to euthanasia, early hospital discharge and/or management errors during emergency
shifts. The study groups lacked significant differences regarding white blood-cell count,
SAA and fibrinogen.
Table 3. Mean and standard deviation/median and of the laboratory parameters examined.
SSG 5DG
Parameter Day Time n Mean ± Standard Deviationor Median (Min–Max) n
Mean ± Standard Deviation
or Median (Min–Max) p
WBC (G/L)
0 variable 30 8.57 ± 2.36 37 9.22 ± 3.68 0.399
1
morning 30 6.81 ± 4.21 37 5.77 ± 2.23 0.202
evening 30 6.36 ± 3.94 37 6.34 ± 2.61 0.957
2
morning 30 5.36 ± 3.45 37 5.47 ± 2.64 0.886
evening 29 4.96 ± 3.24 33 5.24 ± 2.4 0.692
3
morning 29 5 ± 3.06 37 5.17 ± 2.47 0.796
evening 26 5.15 ± 2.9 34 5.48 ± 2.51 0.637
4
morning 27 5.45 ± 2.72 36 5.36 ± 2.05 0.873
evening 25 6.19 ± 2.79 32 5.69 ±1.68 0.407
5
morning 27 6.91 ± 2.36 35 6.94 ± 2.14 0.953
evening 25 7.71 ± 2.17 29 8.01 ± 20.8 0.603
10 morning 25 10.59 ± 3.78 29 10.3 ± 3.74 0.774
SAA (µg/mL)
0 variable 22 13.3 (3.5–748.68) 30 18.4 (3.5–649.36) 0.541
1 morning 28 598.81 ± 163.11 37 602.73 ± 204.1 0.934
2 morning 28 743.71 ± 121.51 33 750.1 ± 196.57 0.882
3 morning 28 781.98 ± 137.87 35 759.57 ± 136.4 0.521
4 morning 26 705.72 ± 167.22 32 732.48 ± 196.82 0.557
5 morning 26 632.55 ± 197.15 29 629.34 ± 226.04 0.956
10 morning 25 110.82 (5.43–783.05) 26 64.93 (3.5–707.62) 0.356
Fibrinogen
(mg/dL)
0 variable 27 188.63 ± 70.52 31 199.26 ± 51.34 0.51
1 morning 30 225.48 ± 72.112 35 231.1 ± 60.35 0.733
2 morning 30 564.86 ± 59.45 34 274.35 ± 63.43 0.54
3 morning 29 270.51 ± 81.81 34 319.19 ± 167.87 0.16
4 morning 27 288.43 ± 72.37 33 306.48 ± 65.79 0.316
5 morning 26 288.29 ± 69.15 32 309.64 ± 76.1 0.273
10 morning 25 285.55 ± 79.77 25 265.36 ± 89.87 0.405
4. Discussion
This study was designed as a randomised pilot study aimed to test for non-inferiority
of the “single-shot” PAP to the conventional “5-day lasting” antibiotic regimen considering
SSI and other adverse effects (i.e., colitis and haemolytic anaemia). Since the 15% non-
inferiority margin was not exceeded, the primary aim of the study, demonstrating the
non-inferiority potential of the single-shot regimen, was achieved. However, caution is
needed with respect to the interpretation of the results presented here, since a rather limited
study power (60%) prohibits general conclusions. While further research on the subject
in terms of clinical trials is clearly needed, the overall sample sizes available are always
limited by the equine patients actually needing colic surgery. A study power of 80%, for
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instance, would require 50 horses per group (total: 100), a number which likely requires a
study period of three years or even more considering our inclusion criteria.
Since most colic surgeries are classified as clean-contaminated [17], horses subjected to
colic surgery should receive PAP. At present, studies reporting on peri- and post-operative
use of antibiotics in equine laparotomy are scarce. A study by Durward-Akhurst et al. did
not find a significant difference in incisional complications comparing a 72 to a 120 h-lasting
antibiotic regimen [17]. Similarly, we could not identify any beneficial effects of a prolonged
administration of antibiotics after colic surgery.
4.1. Surgical Site Infections Following Surgery
The onset of SSI after laparotomy commonly occurs between the 4th and 14th day
after surgery [30–33], which is mostly within the typical 10-day hospitalisation period.
Additionally, a follow-up call, which was admittedly late in many patients, was used to
identify patients that developed SSI within 30 days after colic surgery. Surgical procedures,
general anaesthesia, PAP application and monitoring of the patients following surgery had
been well-standardised due to the study design.
The total SSI rate in the 5DG was 5.4%, and 23.3% in the “single-shot” group (SSG).
Previous research reported SSI rates between 15% and 50% after colic surgery [6,17,20–23].
The PAP regimens used in these studies differed, but most authors reported administration
of a combination of penicillin and gentamicin beyond the immediate 24 h. Even though
SSI occurred more often in horses belonging to the SSG, the results lacked significant
differences. However, the SSI rate of the SSG did not exceed the SSI rates reported for colic
surgery in the literature [6,20–24,34].
4.2. Surgery-Associated Factors
The origin of the intestinal disorder, causing colic, was hypothesised to influence
incisional wound healing. A previous study identified large intestinal obstruction as
a risk factor and suspected exteriorisation of the large intestine to cause trauma to the
incision [35]. However, other authors did not support this hypothesis [36]. Furthermore,
small intestinal lesions and the necessity for anastomosis were both suspected to be risk
factors for SSI [37]. Similar to Mair et al. [5], who could not confirm the hypothesis that
large intestinal lesions predispose to incisional complications, an association between the
(most probable) origin of the gastrointestinal pain and the development of SSI after colic
surgery was not noticeable.
According to Cruse and Foord [2], who classified surgical wounds in humans, to open
a hollow organ such as the intestine is always classified as a clean-contaminated procedure
and, therefore, associated with an increased SSI risk. Accordingly, laparotomy without
enterotomy and/or resection was classified as “clean surgery” and laparotomy including
enterotomy and/or resection was considered as “clean-contaminated surgery”. It seems
likely that clean-contaminated operative interventions are associated with an increased risk
of SSI in horses [38,39] but the studies available did not support this view [35–37,40–42].
Enterotomy and/or resection was not associated with increased SSI rates in this study,
irrespectively of the antibiotic regimen the horse was assigned to.
4.3. Bacteria Associated with SSI in Horses Receiving Colic Surgery
Gram-positive and -negative bacteria residing on the horse’s skin and mucosal sur-
faces are among the common causes of SSI [13]. Previous research on MDR-colonised
horses showed that 10.7% of the horses entering a clinical setting carried ESBL-producing
E. coli [29] and 3.5% MRSA [28]. Consequently, shielding the wound from further damage,
especially an infection caused by MDR bacteria residing on the patient and/or the clinical
environment, is crucial. Incoming colonised horses may spread the MDR bacteria, and
other animals or even humans can become colonised [43]. Once these bacteria cause an
SSI, it is often difficult to treat, since the remaining therapy options are limited [43–47]. In
light of the MDR bacteria associated with SSI identified in this study (Table 1), enhanced
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protection of the incisional wound seems beneficial: Since a previous study reported a
reduction of 45% considering incisional complications by use of abdominal bandages [33],
it seems likely that prolonged application supports wound preservation. However, more
research on this subject is needed.
A significant reduction of SSI was achieved by placing a stent bandage (a sterile cover
sewn over the incision), which was replaced by an abdominal bandage when the horse has
recovered from anaesthesia [23].
To summarise, our results once more underline the importance of adequate hygiene
management in equine clinics, including personal and hand hygiene, patient hygiene
and implementation of proper cleaning/disinfection protocols, as described by several
publications [9,48,49].
4.4. Postoperative Colitis
Five horses suffered from postoperative colitis, and four of them belonged to the 5DG.
Postoperative colitis is a common complication after colic surgery and may be influenced
by the nature of the intestinal lesion, alterations in gut motility, surgical manipulation
of the intestines and antibiotics disrupting the physiological gastrointestinal bacterial
ecosystem [50–52]. The reasons for colitis following administration of antibiotics are
multifactorial, but an important factor is the unavoidable change of the structure and
composition of the gastrointestinal microbiota, which is particularly associated with the
administration of antibiotics [53,54].
In particular, NSAIDs are also known to be the cause of (postoperative) colitis. These
drugs are not only associated with gastric ulceration but also with right dorsal colitis and
a delayed mucosal healing [55–59]. The five horses suffering from postoperative colitis
received a standard course of NSAIDs (5 days, 1.1 mg/kg flunixin-meglumine BID) after
surgery. Previous studies identified horses suffering from large intestinal lesions being
associated with an increased risk of postoperative colitis, while detection of Clostridia spp.
and Salmonella seemed of lesser importance [60,61]. Only 2/5 faecal samples from horses
with colitis were culture-positive for Clostridium perfringens. The causes of postoperative
colitis in the remaining patients were possibly associated with a combination of the factors
mentioned above, since most of the horses had primary large intestinal lesions (Table 2)
and received antibiotics for 5 days after surgery and NSAID. Since four out of the five
patients that developed postoperative colitis received the prolonged PAP regimen, further
research on the particular effects of PAP on the equine intestinal microbiome is warranted.
4.5. Haemolytic Anaemia
Three horses developed haemolytic anaemia. Penicillin-induced immune-mediated
haemolytic anaemia is a well-described phenomenon in equine literature and is considered
as a severe clinical complication associated with prolonged administration of the antibiotic.
The proposed pathomechanism causing haemolysis is associated with the interaction of
anti-penicillin IgG antibodies with penicillin-coated equine erythrocytes [62–65]. Of note,
only horses belonging to the 5DG have developed haemolytic anaemia, although the
difference is lacking significance. Since all horses have recovered quickly after suspension
of further antibiotic courses, administration of penicillin seems to be the most likely cause
for the anaemic condition of these patients.
Heparin is commonly used to treat haemostatic abnormalities in horses suffering
from severe gastrointestinal diseases, septicaemia and endotoxemia [66]. The horses in
the present study received either un-fractioned or low-molecular heparin. Heparin may
cause a regenerative, macrocytic anaemia and extravascular haemolysis by opsonisation of
erythrocytes, which induces their early phagocytosis [67,68]. Other theories suspected that
heparin may act as a hapten for antibody-mediated erythrocyte agglutination [69], similar
to the pathomechanisms discussed for human immune-mediated thrombocytopenia [70].
A further hypothesis is that a decreased plasma proteolytic activity allows for protein
adherence to red blood cells, followed by their agglutination [71].
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5. Conclusions
Perioperative prophylaxis in terms of a single-shot antibiotic regimen has the potential
to be non-inferior to the commonly used antibiotic regimen lasting five days following
colic surgery. Further clinical trials on the subject are needed.
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